Amulan, Sundosin .

HRN: 05-46-93  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/11/2023
CEFUROXIME 500MG (TAB)
04/11/2023
04/18/2023
PO
500mg
BID
2 Degree RMLE
Waiting Final Action 
04/11/2023
METRONIDAZOLE 500MG (TAB)
04/11/2023
04/18/2023
PO
500mg
TID
TMSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: